These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 11996015)

  • 1. Summary of information on human CYP enzymes: human P450 metabolism data.
    Rendic S
    Drug Metab Rev; 2002; 34(1-2):83-448. PubMed ID: 11996015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.
    Rendic S; Guengerich FP
    Curr Drug Metab; 2010 Jan; 11(1):4-84. PubMed ID: 20302566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Summary of information on the effects of ionizing and non-ionizing radiation on cytochrome P450 and other drug metabolizing enzymes and transporters.
    Rendic S; Guengerich FP
    Curr Drug Metab; 2012 Jul; 13(6):787-814. PubMed ID: 22571481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Updates on cytochrome P450-mediated cardiovascular drug interactions.
    Cheng JW; Frishman WH; Aronow WS
    Am J Ther; 2009; 16(2):155-63. PubMed ID: 19114873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP-allele) Nomenclature Database.
    Sim SC; Ingelman-Sundberg M
    Methods Mol Biol; 2013; 987():251-9. PubMed ID: 23475683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling human cytochromes P450 for evaluating drug metabolism: an update.
    Lewis DF
    Drug Metabol Drug Interact; 2000; 16(4):307-24. PubMed ID: 11201309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics.
    Martinez MN; Antonovic L; Court M; Dacasto M; Fink-Gremmels J; Kukanich B; Locuson C; Mealey K; Myers MJ; Trepanier L
    Drug Metab Rev; 2013 May; 45(2):218-30. PubMed ID: 23432217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
    Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
    J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro.
    Lübberstedt M; Müller-Vieira U; Mayer M; Biemel KM; Knöspel F; Knobeloch D; Nüssler AK; Gerlach JC; Zeilinger K
    J Pharmacol Toxicol Methods; 2011; 63(1):59-68. PubMed ID: 20460162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.
    Uno Y; Uehara S; Yamazaki H
    Biochem Pharmacol; 2016 Dec; 121():1-7. PubMed ID: 27318253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R; Liu J; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human hepatic cell cultures: in vitro and in vivo drug metabolism.
    Gómez-Lechón MJ; Donato T; Ponsoda X; Castell JV
    Altern Lab Anim; 2003; 31(3):257-65. PubMed ID: 15612868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cDNA-expressed human cytochrome P450 enzymes to study potential drug-drug interactions.
    Crespi CL; Penman BW
    Adv Pharmacol; 1997; 43():171-88. PubMed ID: 9342176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cytochromes P450 associated with the phase 1 metabolism of drugs and other xenobiotics: a compilation of substrates and inhibitors of the CYP1, CYP2 and CYP3 families.
    Lewis DF
    Curr Med Chem; 2003 Oct; 10(19):1955-72. PubMed ID: 12871098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.
    Lewis DF
    Biochem Pharmacol; 2000 Aug; 60(3):293-306. PubMed ID: 10856424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic selectivity of human cytochrome P450 enzymes: relevance to drug metabolism and toxicity.
    Guengerich FP
    Toxicol Lett; 1994 Feb; 70(2):133-8. PubMed ID: 8296317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of cytochrome P450 mediated metabolism.
    Olsen L; Oostenbrink C; Jørgensen FS
    Adv Drug Deliv Rev; 2015 Jun; 86():61-71. PubMed ID: 25958010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of CKD on Cytochrome P450-Mediated Drug Metabolism.
    Ladda MA; Goralski KB
    Adv Chronic Kidney Dis; 2016 Mar; 23(2):67-75. PubMed ID: 26979145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.